Ha habido 50 transacciones internas recientes registradas para Reneo Pharmaceuticals, Inc. (RPHM), incluyendo 40 compras y 6 ventas. El total de compras internas fue valorado en $3.98M y el total de ventas internas en $1.5M.
Internos destacados con actividad reciente incluyen Leonard Braden Michael, Hall Ashley, Grey Michael G. Las transacciones internas pueden proporcionar información sobre cómo la dirección de la empresa ve la valoración y perspectivas futuras de la acción.
Operaciones de Insiders — RPHM
| Fecha |
Nombre |
Cargo |
Tipo de Transacción |
Acciones |
Precio Promedio |
Valor |
Acciones en Propiedad |
| 2024-09-25 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
68,746 |
$1.50 |
$102.87K |
3,457,395 |
| 2024-09-24 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
29,600 |
$1.41 |
$41.87K |
3,388,649 |
| 2024-09-18 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
806 |
$1.40 |
$1.13K |
3,359,049 |
| 2024-09-17 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
55,300 |
$1.36 |
$75.11K |
3,358,243 |
| 2024-09-16 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
172,747 |
$1.37 |
$236.87K |
3,302,943 |
| 2024-09-13 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
150,000 |
$1.31 |
$196.95K |
3,130,196 |
| 2024-09-12 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
36,176 |
$1.40 |
$50.52K |
2,980,196 |
| 2024-08-14 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
100,487 |
$1.41 |
$142.01K |
2,944,020 |
| 2024-08-13 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
171,339 |
$1.39 |
$238.59K |
2,843,533 |
| 2024-05-14 |
Leonard Braden Michael |
10 Percent Owner |
Disposición |
- |
- |
- |
1,020,769 |
| 2024-05-14 |
Leonard Braden Michael |
10 Percent Owner |
Compra Informativa |
79,281 |
$1.56 |
$123.68K |
2,337,194 |
| 2023-08-28 |
Hall Ashley |
Chief Development Officer |
Venta Informativa |
15,625 |
$6.28 |
$98.06K |
39,600 |
| 2023-07-26 |
Grey Michael G |
Executive Chairman |
Donación (Otorgada) |
50,000 |
- |
- |
- |
| 2023-06-23 |
Novo Holdings A/s |
10 Percent Owner |
Venta Informativa |
100,000 |
$7.10 |
$709.74K |
3,330,337 |
| 2023-06-06 |
Grey Michael G |
Executive Chairman |
Concesión de RSU |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Mathers Edward T |
Director |
Devolución de RSU |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Hoelscher Paul W. |
Director |
Concesión de RSU |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Seltzer Stacey Denenberg |
Director |
Concesión de RSU |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Dube Eric M |
Director |
Concesión de RSU |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
O'donnell Niall |
Director |
Concesión de RSU |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Muralidhar Bali |
Director |
Concesión de RSU |
17,500 |
$9.01 |
$157.68K |
17,500 |
| 2023-06-06 |
Blunt Roshawn A. |
Director |
Concesión de RSU |
14,815 |
$9.01 |
$133.48K |
14,815 |
| 2023-05-08 |
O'donnell Niall |
Director |
Compra Informativa |
125,000 |
$8.00 |
$1M |
2,188,713 |
| 2022-12-09 |
Dorenbaum Alejandro |
Chief Medical Officer |
Concesión de RSU |
125,000 |
- |
- |
125,000 |
| 2022-12-09 |
Flesher Gregory J. |
President and CEO |
Concesión de RSU |
300,000 |
- |
- |
300,000 |
| 2022-12-09 |
Hall Ashley |
Chief Development Officer |
Concesión de RSU |
125,000 |
- |
- |
125,000 |
| 2022-12-09 |
Cruse Michael |
Chief Operating Officer |
Concesión de RSU |
125,000 |
- |
- |
125,000 |
| 2022-12-09 |
Lam Jennifer |
VP of Finance & Administration |
Concesión de RSU |
90,000 |
- |
- |
90,000 |
| 2022-09-01 |
Cruse Michael |
Chief Operating Officer |
Compra Informativa |
7,500 |
$3.39 |
$25.45K |
13,697 |
| 2022-08-31 |
Grey Michael G |
Executive Chairman |
Ejercicio de Opciones |
50,000 |
$1.97 |
$98.5K |
50,000 |
| 2022-08-29 |
Cruse Michael |
Chief Operating Officer |
Compra Informativa |
3,212 |
$3.21 |
$10.31K |
6,197 |
| 2022-08-12 |
Dorenbaum Alejandro |
Chief Medical Officer |
Donación (Otorgada) |
22,348 |
- |
- |
30,000 |
| 2022-08-02 |
Blunt Roshawn A. |
Director |
Desconocido |
- |
- |
- |
- |
| 2022-08-02 |
Blunt Roshawn A. |
Director |
Concesión de RSU |
35,000 |
$2.80 |
$98K |
35,000 |
| 2022-06-01 |
Grey Michael G |
Executive Chairman |
Concesión de RSU |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
Mathers Edward T |
Director |
Concesión de RSU |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
Hoelscher Paul W. |
Director |
Concesión de RSU |
6,376 |
- |
- |
6,376 |
| 2022-06-01 |
Seltzer Stacey Denenberg |
Director |
Concesión de RSU |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
Dube Eric M |
Director |
Concesión de RSU |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-06-01 |
O'donnell Niall |
Director |
Concesión de RSU |
17,500 |
- |
- |
17,500 |
| 2022-06-01 |
Muralidhar Bali |
Director |
Concesión de RSU |
17,500 |
$2.09 |
$36.58K |
17,500 |
| 2022-03-31 |
Lam Jennifer |
VP of Finance & Administration |
Disposición |
10,000 |
$4.58 |
$45.8K |
- |
| 2022-03-02 |
Cruse Michael |
Chief Operating Officer |
Concesión de RSU |
25,000 |
- |
- |
25,000 |
| 2022-01-20 |
Hoelscher Paul W. |
Director |
Desconocido |
- |
- |
- |
- |
| 2022-01-20 |
Hoelscher Paul W. |
Director |
Concesión de RSU |
35,000 |
$8.01 |
$280.35K |
35,000 |
| 2021-12-10 |
Dorenbaum Alejandro |
Chief Medical Officer |
Concesión de RSU |
30,000 |
- |
- |
52,348 |
| 2021-12-10 |
Flesher Gregory J. |
President and CEO |
Concesión de RSU |
100,000 |
- |
- |
109,600 |
| 2021-12-10 |
Cruse Michael |
Senior VP-corporate Operations |
Concesión de RSU |
25,000 |
- |
- |
29,100 |
| 2021-12-10 |
Jindal Vineet R. |
Chief Financial Officer |
Concesión de RSU |
30,000 |
- |
- |
36,600 |
| 2021-12-09 |
Grey Michael G |
Executive Chairman |
Disposición |
100,563 |
$4.88 |
$490.75K |
- |
■ Informativa — transacción en mercado abierto (más significativa)
■ No informativa (compra) — premio, ejercicio de opción, conversión
■ No informativa (venta) — retención fiscal, venta de adjudicación
■ Neutral — regalo, fideicomiso, vencimiento
